HIF1A and cancer: Additionally, other autoantibodies targeting SOX2, HIF1-α, NY-ESO-1/CTAG1B, MUC1, Her2, GAL1, and GAL3 have been frequently identified in cancer patients [16,18,19,20,21,22].